M. Janssen

发表

NMR evaluation of changes in myocardial high energy metabolism produced by repeated short periods of ischemia.

S. Bradamante, J. D. de Jong, F. Piccinini, 1995, Biochimica et biophysica acta.

Controversies in preconditioning

R. Jonge, S. Bradamante, A. Marchesani, 2004, Cardiovascular Drugs and Therapy.

Intermittent v continuous ischemia decelerates adenylate breakdown and prevents norepinephrine release in reperfused rabbit heart.

R. Ferrari, E. Pasini, R. Bünger, 1995, Journal of molecular and cellular cardiology.

Malondialdehyde and glutathione production in isolated perfused human and rat hearts.

E. Bos, J. Koster, J. D. de Jong, 1993, Circulation research.

Antioxidant defences in rat, pig, guinea pig, and human hearts: comparison with xanthine oxidoreductase activity.

P. van der Meer, J. D. de Jong, M. Janssen, 1993, Cardiovascular research.

Formation and breakdown of uridine in ischemic hearts of rats and humans.

M. Yacoub, R. Smolenski, J. D. de Jong, 1993, Journal of molecular and cellular cardiology.

In vitro and ex vivo xanthine oxidoreductase activity in rat and guinea-pig hearts using hypoxanthine or xanthine as substrate.

J. Koster, J. D. de Jong, M. Janssen, 1993, Biochimica et biophysica acta.

Purines, free radicals and antioxidant systems : a study in hearts of various species, including humans

M. Janssen, 1993 .

Adenosine, added to St Thomas' Hospital cardioplegic solution, improves functional recovery and reduces irreversible myocardial damage.

M. Arad, C. van der Lee, J. D. de Jong, 1994, Cardioscience.

High-energy phosphates and their catabolites

R. Krams, P. Verdouw, J. Jong, 1993 .

Uridine and purine nucleoside phosphorylase activity in human and rat heart.

M. Yacoub, R. Smolenski, J. D. de Jong, 1991, Advances in experimental medicine and biology.